What a fantastic few days in Weisbaden, Germany, at the 6th Theranostics World Congress. Being able to meet with colleagues in person after so many years, sharing cutting edge research, best practices and projects and putting the patient and patient advocate at the centre of the conversation.
Watch this space as we look to collaborate with overseas and national researchers and industry to ensure new clinical trials open here for our neuroendocrine cancer patients. Thank you Oncidium Foundation, ICOP and the Theranostics World Congress organising committee led by Prof Richard Baum.
